Baxter International Inc. (NYSE: BAX) on Monday, plunged -2.42% from the previous trading day, before settling in for the closing price of $38.91. Within the past 52 weeks, BAX’s price has moved between $31.01 and $44.01.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 6.04%. The company achieved an average annual earnings per share of 14.16%. With a float of $506.32 million, this company’s outstanding shares have now reached $507.63 million.
Let’s determine the extent of company efficiency that accounts for 60000 employees.
Baxter International Inc. (BAX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Medical Instruments & Supplies industry stocks is more important than anything else. The insider ownership of Baxter International Inc. is 0.76%, while institutional ownership is 91.24%. The most recent insider transaction that took place on Sep 16 ’24, was worth 39,046. Before that another transaction happened on Sep 13 ’24, when Company’s Officer proposed sale 16,063 for $39.81, making the entire transaction worth $639,465.
Baxter International Inc. (BAX) Recent Fiscal highlights
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.68 earnings per share (EPS) for the period topping the consensus outlook (set at 0.67) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.87 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.16% per share during the next fiscal year.
Baxter International Inc. (NYSE: BAX) Trading Performance Indicators
Baxter International Inc. (BAX) is currently performing well based on its current performance indicators. A quick ratio of 0.91 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.29. Likewise, its price to free cash flow for the trailing twelve months is 37.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.80, a number that is poised to hit 0.78 in the next quarter and is forecasted to reach 3.15 in one year’s time.
Technical Analysis of Baxter International Inc. (BAX)
Looking closely at Baxter International Inc. (NYSE: BAX), its last 5-days average volume was 3.1 million, which is a drop from its year-to-date volume of 4.14 million. As of the previous 9 days, the stock’s Stochastic %D was 31.02%. Additionally, its Average True Range was 0.90.
During the past 100 days, Baxter International Inc.’s (BAX) raw stochastic average was set at 68.54%, which indicates a significant increase from 20.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.43% in the past 14 days, which was lower than the 26.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.37, while its 200-day Moving Average is $38.08. However, in the short run, Baxter International Inc.’s stock first resistance to watch stands at $38.29. Second resistance stands at $38.62. The third major resistance level sits at $39.10. If the price goes on to break the first support level at $37.48, it is likely to go to the next support level at $37.00. Now, if the price goes above the second support level, the third support stands at $36.67.
Baxter International Inc. (NYSE: BAX) Key Stats
Market capitalization of the company is 19.37 billion based on 509,580K outstanding shares. Right now, sales total 14,813 M and income totals 2,656 M. The company made 3,812 M in profit during its latest quarter, and -314,000 K in sales during its previous quarter.
